• OFID 2018:5 (Suppl 1) • Poster Abstracts a newly developed protocol based on red blood cell lysis and differential centrifugation of bacteria, followed by VITEK®2 card set-up. VITEK®2 results from the direct method were compared with a reference method (VITEK®2 results using a 24-hour colony).
Background. Automation minimizes hands-on steps and facilitates process improvement in the microbiology laboratory. The impact on the efficiency improvement of the culturing process in an academic regional hospital after implementation of total laboratory automation (TLA) was evaluated.
Methods. After approval from the Quality Improvement Review Board, a retrospective analysis of microbiological data in Becton Dickenson (BD) Clinical Insights Research Database was performed. Then, laboratory process change and reported microbiological results turnaround time (TAT) before and after implementation of the TLA was compared (2013 vs. 2016 ). Specimens were classified into blood, respiratory, urine, wound and others. Statistical analysis was performed with SAS software version 9.2. The comparison was done using chi-square test for categorical and log-transformed t-test for continuous variables. A P-value of < 0.05 was considered statistically significant.
Results. A total of 9,351 pre-defined common and clinically important positive mono-microbial culture results were included in the organism identification (ID) TAT analysis. The time of the day at which results were reported in 2016 was more evenly distributed throughout a 24-hour period, rather than delaying to the following morning (P < 0.0001). The definitive positive bacterial pathogen identification TAT was significantly shorter across all sources in 2016 compared with 2013 with overall TAT mean (standard deviation) of 56.8 (24.3) hours in 2013 vs. 43.3 (20.8) hours in 2016 (P < 0.0001). The negative results' (n = 58,640) TAT was also shortened in 2016 for all (P < 0.05), except for respiratory and other sources.
Conclusion. Automation facilitates microbiological laboratory efficiency improvement with shorter definitive organism identification TAT across all specimens as well as shorter TAT for negative results with most specimen sources. This information would facilitate earlier, more accurate and appropriate antibiotic choices which in turn improves clinical decision making and enhances optimal patient care.
Disclosures Background. Detection of bacteremia directly from blood may improve time to clinical diagnosis and initiation of appropriate antibiotic therapy for hospitalized patients. Administration of empiric antibiotic therapy, whether prior to standard of care (SOC) or research study blood collection, adds to challenges in bacterial recovery. Strategies to improve detection were explored in this pilot study to inform future clinical trial design (CTD) on Enterobacteriaceae (ENT) detection directly from blood. One of the objectives was to assess effects of prior antibiotic administration on novel assay performance.
Methods. Confirmed ENT bacteremic (Protocol A (P-A), n = 26), and suspected bacteremic (Protocol B (P-B), n = 25) participants were enrolled into one of two IRB approved protocols after obtaining informed consent. Fresh whole blood (20 mL) was collected within 12 hours of SOC blood culture positivity (P-A) or 20 hours of SOC blood culture collection (P-B), and divided: 10 mL inoculated into a lytic media collection vessel (P-A and B); and 10 mL into a BD BACTEC™ Bottle (P-A) as a control, or an Isolator™ lysis centrifugation tube (P-B) for quantification. For collection vessels, a 3-hour amplification step in lytic growth medium followed by cleanup and concentration steps was employed. Processed samples were tested using an investigational assay for universal bacterial detection on the Accelerate Pheno™ system. Results were analyzed manually and with proprietary software. Descriptive statistics were performed to inform future CTD.
Results. Empiric antibiotic therapy was initiated prior to blood collection in 89% (P-A) and 36% (P-B) of participants. Improved detection sensitivity was achieved in P-B over P-A, when a study sample was obtained prior to empiric antibiotic therapy initiation (Table 1) .
Conclusion.
Prior antibiotic administration and low bacterial load in clinical samples affects ability to detect ENT directly from blood. Multiple factors are critical to address in future CTD to increase sensitivity of detecting ENT directly from blood including: (1) Targeting study samples prior to antibiotic therapy initiation and (2) Using enzymatic methods to neutralize antibiotics present in the blood.
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